Floatz logo

Jskn016

Advanced Malignant Solid Tumor

Jiangsu Alphamab Biopharmaceuticals Co., LtdPhase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
73/ 100

Competitive context

31 Active assets in the Advanced Malignant Solid Tumor cohort.

Asset / SponsorPhaseRating
mhb039a
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 2CCC
mhb039a for
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 2CCC
mhb036c for
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 2CCC
Cannabis Oil
National Cancer Institute, Naples
Phase 2CCC
mhb036c
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 2CCC

View all 38 →

Same molecule, other indications

Jskn016 is also rated in:

non-small cell lung carcinomaDormant
B
Indicative ·
58 / 100
View asset →
triple-negative breast carcinomaDormant
CCC
Indicative ·
52 / 100
View asset →
Locally Advanced Breast Cancer (LABC)Dormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →